Literature DB >> 14746623

Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study.

M H Sandström1, J Faergemann.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a chronic relapsing skin disease. Several investigations concerning the long-term prognosis of AD among children and teenagers have been performed but there are only few data among adults.
OBJECTIVES: To investigate the prognosis and prognostic factors in adult patients with AD by a long-term follow-up (25-38 years). The prognostic factors were defined as those factors of importance for the persistence of AD. PATIENTS AND METHODS: A follow-up questionnaire was sent in November/December 1998 to 922 AD patients examined in our outpatient clinic between 1960 and 1973 among 1366 registered patients with AD. The patients were aged 20 years or older when they visited the clinic and 45 years or older when they answered the follow-up questionnaire.
RESULTS: The response rate was 90.4%. The age range at the time of follow-up was 45-86 years (mean 55 years). Of the 833 patients who responded, 59% reported AD at some time during the last 12 months, which we defined as persistent AD. The mean value of clearance rate per person-years was 18%. One of the most important factors associated with persistence of AD was a head and neck dermatitis with or without other AD locations at the time of examination according to the old patient records.
CONCLUSIONS: This study showed that the majority of adults with AD still had AD when they became older. This applies particularly if negative prognostic factors existed.

Entities:  

Mesh:

Year:  2004        PMID: 14746623     DOI: 10.1111/j.1365-2133.2004.05711.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Immunoglobulin e, interleukin-18 and interleukin-12 in patients with atopic dermatitis: correlation with disease activity.

Authors:  Khaled Zedan; Zafar Rasheed; Yaser Farouk; Abdullateef A Alzolibani; Ghada Bin Saif; Hisham A Ismail; Ahmad A Al Robaee
Journal:  J Clin Diagn Res       Date:  2015-04-01

Review 2.  Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice.

Authors:  Raj Chovatiya; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2022-05-31       Impact factor: 6.233

Review 3.  Specific immunotherapy in atopic dermatitis.

Authors:  Jungsoo Lee; Chang Ook Park; Kwang Hoon Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-25       Impact factor: 5.764

4.  Clinical Features of Atopic Dermatitis in Adults Are Different according to Onset.

Authors:  Jee Hee Son; Bo Young Chung; Hye One Kim; Chun Wook Park
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

Review 5.  Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.

Authors:  A D Irvine; P Mina-Osorio
Journal:  Br J Dermatol       Date:  2019-05-15       Impact factor: 9.302

6.  The epidemiology of atopic dermatitis in older adults: A population-based study in the United Kingdom.

Authors:  Leslie N Chan; Alexa Magyari; Morgan Ye; Noor A Al-Alusi; Sinead M Langan; David Margolis; Charles E McCulloch; Katrina Abuabara
Journal:  PLoS One       Date:  2021-10-06       Impact factor: 3.240

7.  Impairment of Quality of Life and Mental Health Status in Adult-Onset Atopic Dermatitis.

Authors:  Juhwan Yoo; Ha Yeh Rin Koo; Kyungdo Han; Young Bok Lee
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

8.  Adult onset atopic dermatitis: Under-recognized or under-reported?

Authors:  Amrinder Jit Kanwar; Tarun Narang
Journal:  Indian Dermatol Online J       Date:  2013-07

9.  Associations of sleep characteristics with atopic disease: a cross-sectional study among Chinese adolescents.

Authors:  Yiting Chen; Qian Yang; Kena Zhao; Zengqiang Wu; Xiaoming Shen; Shenghui Li
Journal:  Allergy Asthma Clin Immunol       Date:  2021-02-22       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.